GlassScriptPhysician profile
Nicholas P Bruno
NPI 1053413484
$1,200.29
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $366.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $183.75 | 2019-2020 | |
| Amgen INC. | $180.61 | 2019-2020 | |
| Celgene Corporation | $167.32 | 2019 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $106.82 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $98.48 | 2019-2020 | |
| Abbvie INC. | $83.90 | 2019 | |
| Journey Medical Corporation | $53.22 | 2019 | |
| Pfizer INC. | $47.80 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $34.80 | 2019 | |
| Ucb, INC. | $33.99 | 2020 | |
| Vyne Pharmaceuticals INC. | $19.27 | 2020 | |
| Lilly USA, LLC | $18.04 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $16.71 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.77 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $14.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Bruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.